DGAP-News: MediClin AG / Key word(s): Final Results MediClin Continues to Grow Further 30.03.2017 / 16:30 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MediClin Continues to Grow Further Offenburg, 30 March 2017 - The Management Board of MEDICLIN Aktiengesellschaft (MediClin) showed himself satisfied with the business development of the 2016 financial year at this year's press conference. Clearly increased Group sales and a Group-EBIT slightly above previous year's level were presented. "We have changed our performance portfolio very targeted in the last couple of years - partly through capacity expansions but also through capacity adjustments", said Jens Breuer, CFO of MediClin. And he added: "The changes always took place under the premises that the demand for the service exists and the seasonal effects are getting more moderate and the service will be higher reimbursed". For the 2017 financial year the Management Board forecasts Group sales growth similar to the previous year, that is between 4.0% and 5.0% and a Group-EBIT slightly above previous year's level between EUR 25 und EUR 27 million. MediClin offers first-rate medical services in areas of expertise MediClin will grow further in the future. The areas of expertise are neurology, cardiology, orthopaedics and psychosomatic and psychiatric conditions. "In these specialist fields we offer first-rate medical services for certain treatments, which we have bundled under the term "excellence", said Volker Hippler, CEO of MediClin and added: "Patients and their relatives as well as coverage providers can thus easily obtain information on our specific medical and therapeutic expertise also on www.mediclin-exzellenz.de. For the benefit of the patients: Integrated medical care The extension of integrated medical care is part of MediClin's company strategy right from the beginning. MediClin takes the advantages resulting from a close cooperation between acute medicine and rehabilitation. "Clinics which, in addition to their rehabilitation services, offer medical services in acute neurology and acute psychosomatics in the scope of their integrated care concept contributed considerably to the performance in 2016", said Ulf Ludwig, COO, and responsible for the business areas rehabilitation and nursing care. Summary of the development of the Group and the Segments. Group sales in the amount of EUR 580.3 mill. increased compared to the previous year by EUR 25.0 mill. or 4.5 %. The post-acute segment contributed the largest share to sales growth of EUR 20.1 mill. The Group-EBIT rose from EUR 23.6 mill. to EUR 24.0 mill. The result attributable to shareholders of MediClin AG amounts to EUR 16.5 mill., same as in the 2015 financial year; earnings per share are EUR 0.35 (previous year: EUR 0.35). Development of the Segments Sales increased in the post-acute segment by EUR 20.1 mill. from EUR 330.9 mill. to EUR 351.0 mill. The clinics which offer exclusively rehabilitation services added to the sales plus as well as the clinics which offer additional medical services in acute neurology and acute psychosomatics in the scope of an integrated care concept. Sales in the acute segment improved by EUR 3.9 mill. from EUR 206.7 mill. to EUR 210.6 mill. and in the nursing care business area from EUR 14.1 mill. to EUR 14.7 mill. The post-acute segment result improved by EUR 4.6 mill. from EUR 13.9 mill. to EUR 18.5 mill., the segment EBIT-margin accounts for 5.3 %. The acute segment result reduced by EUR 2.9 mill. from EUR 8.7 mill. to EUR 5.8 mill. due to increased expenses. The segment EBIT-margin accounts for 2.8 %. MediClin is well positioned: Sound financial structure and stable results of operation The equity ratio is 52.3 %, and the net financial debt amounts to EUR 7.1 mill. In addition to cash and cash equivalents of EUR 41.6 mill. (previous year: EUR 29.5 mill.) the Group has sufficient credit lines to support capacity expansions in MediClin's medical focus areas as well as to generate additional sales. Hight investments secure growth In the 2016 financial year EUR 28.1 mill. (previous year: EUR 27.0 mill.) were invested in non-current assets (gross amount), including subsidies in the amount of EUR 6.4 mill. (previous year: EUR 2.7 mill.). EUR 18,5 mill. (previous year: EUR 16.7 mill.) was spent on maintenance and repair. The 2016 Annual Report is available on our website in German and English. www.mediclin.de About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34 clinics, 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of close to 8,100 beds. MediClins' facilities include acute care clinics, general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment as well as medical rehabilitation. MediClin has approximately 9,300 employees. Important notice: This press release includes future-oriented statements which are based on assumptions and estimates. While MediClin AG is of the opinion that these assumptions and estimates are correct, the actual future developments and actual future results may deviate from these assumptions and estimates due to the impact of various factors such as changes in the economic conditions in Germany, legal changes concerning the health system, changes relating to cost providers' expense behaviour. MediClin does not assume liability and gives no warranty that future developments and the income actually achieved in the future will comply with the assumptions and estimates stated in this press release. --------------------------------------------------------------------------- 30.03.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-326 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 560343 30.03.2017